NHC
VENTE TOTALE: 3 279 titres (~756 642,18 $ US)
- Insiders
- Gifford David R., Flatt Stephen Fowler
- Total bought
- —
- Total sold
- $756,642
- Last activity
- 2026-08-25
- Last synced
-
2026-08-31 10:14:36
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-31
NHC exhibits strong financial health with high liquidity (90) and solid fundamental trends (85), reflecting robust balance sheet management and consistent margin expansion.
The first sentence of the analysis written for NHC on 2026-08-31 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 39.3% | 37.5% | 37.6% | 36.1% | 34.1% | |
| Ebit Margin | 11.1% | 10.8% | 7.8% | 2.6% | 14.9% | |
| Ebitda Margin | 14.1% | 14.1% | 11.5% | 6.4% | 18.9% | |
| Operating Profit Margin | 8.5% | 6.6% | 5.0% | 3.0% | 5.0% | |
| Pretax Profit Margin | 10.7% | 10.5% | 7.8% | 2.5% | 14.8% | |
| Continuous Operations Profit Margin | 8.1% | 7.9% | 5.7% | 1.9% | 13.8% | |
| Net Profit Margin | 7.9% | 7.9% | 5.9% | 2.1% | 13.7% | |
| Bottom Line Profit Margin | 7.9% | 7.9% | 5.9% | 2.1% | 13.7% | |
| Current Ratio | 1.767 | 1.808 | 1.894 | 1.789 | 1.621 | |
| Quick Ratio | 1.767 | 1.769 | 1.860 | 1.753 | 1.588 | |
| Solvency Ratio | 0.365 | 0.266 | 0.272 | 0.158 | 0.362 | |
| Cash Ratio | 0.437 | 0.324 | 0.499 | 0.296 | 0.409 | |
| Price To Earnings Ratio | 17.666 | 16.248 | 21.197 | 40.753 | 7.524 | |
| Price To Earnings Growth Ratio | 1.026 | 0.313 | 0.107 | -0.486 | 0.033 | |
| Forward Price To Earnings Growth Ratio | 1.026 | 0.313 | 0.107 | -0.486 | 0.033 | |
| Price To Earnings Diluted Ratio | 17.874 | 16.472 | 21.295 | 41.034 | 7.557 | |
| Price To Earnings Diluted Growth Ratio | 1.024 | 0.326 | 0.107 | -0.489 | 0.033 | |
| Price To Book Ratio | 1.985 | 1.689 | 1.557 | 1.049 | 1.155 | |
| Price To Sales Ratio | 1.397 | 1.276 | 1.240 | 0.854 | 1.031 | |
| Price To Free Cash Flow Ratio | 14.271 | 20.774 | 16.983 | -42.730 | 45.344 | |
| Price To Operating Cash Flow Ratio | 11.460 | 15.431 | 12.723 | 104.885 | 16.711 | |
| Debt To Assets Ratio | 0.057 | 0.141 | 0.071 | 0.099 | 0.119 | |
| Debt To Equity Ratio | 0.081 | 0.219 | 0.103 | 0.144 | 0.185 | |
| Debt To Capital Ratio | 0.075 | 0.180 | 0.093 | 0.126 | 0.156 | |
| Long Term Debt To Capital Ratio | 0.030 | 0.117 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.428 | 1.555 | 1.442 | 1.459 | 1.554 | |
| Working Capital Turnover Ratio | 7.902 | 6.807 | 6.564 | 6.725 | 5.965 | |
| Operating Cash Flow Ratio | 0.730 | 0.457 | 0.519 | 0.044 | 0.237 | |
| Operating Cash Flow Sales Ratio | 0.122 | 0.083 | 0.097 | 0.008 | 0.062 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.803 | 0.743 | 0.749 | -2.455 | 0.369 | |
| Debt Service Coverage Ratio | 3.662 | 12.738 | 332.241 | 108.400 | 213.733 | |
| Interest Coverage Ratio | 20.146 | 20.740 | 176.340 | 56.654 | 60.266 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.502 | 14.307 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 2.126 | 0.500 | 1.191 | 0.069 | 0.374 | |
| Capital Expenditure Coverage Ratio | 5.078 | 3.888 | 3.986 | 0.289 | 1.584 | |
| Dividend Paid And Capex Coverage Ratio | 2.463 | 1.662 | 1.753 | 0.135 | 0.874 | |
| Dividend Payout Ratio | 0.322 | 0.363 | 0.532 | 1.542 | 0.231 | |
| Enterprise Value Multiple | 9.813 | 9.831 | 10.689 | 14.413 | 5.752 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 39.3% | ▲1.8% | ▲2.4% |
| Ebit Margin | 11.1% | ▲0.3% | ▲1.7% |
| Ebitda Margin | 14.1% | ▲0.0% | ▲1.1% |
| Operating Profit Margin | 8.5% | ▲1.8% | ▲2.8% |
| Pretax Profit Margin | 10.7% | ▲0.2% | ▲1.4% |
| Continuous Operations Profit Margin | 8.1% | ▲0.2% | ▲0.6% |
| Net Profit Margin | 7.9% | ▲0.1% | ▲0.4% |
| Bottom Line Profit Margin | 7.9% | ▲0.1% | ▲0.4% |
| Current Ratio | 1.767 | ▼-0.041 | ▼-0.009 |
| Quick Ratio | 1.767 | ▼-0.002 | ▲0.020 |
| Solvency Ratio | 0.365 | ▲0.099 | ▲0.080 |
| Cash Ratio | 0.437 | ▲0.113 | ▲0.044 |
| Price To Earnings Ratio | 17.666 | ▲1.419 | ▼-3.011 |
| Price To Earnings Growth Ratio | 1.026 | ▲0.712 | ▲0.827 |
| Forward Price To Earnings Growth Ratio | 1.026 | ▲0.712 | ▲0.827 |
| Price To Earnings Diluted Ratio | 17.873 | ▲1.402 | ▼-2.973 |
| Price To Earnings Diluted Growth Ratio | 1.024 | ▲0.697 | ▲0.824 |
| Price To Book Ratio | 1.985 | ▲0.295 | ▲0.498 |
| Price To Sales Ratio | 1.397 | ▲0.122 | ▲0.238 |
| Price To Free Cash Flow Ratio | 14.271 | ▼-6.503 | ▲3.342 |
| Price To Operating Cash Flow Ratio | 11.460 | ▼-3.970 | ▼-20.782 |
| Debt To Assets Ratio | 0.057 | ▼-0.084 | ▼-0.040 |
| Debt To Equity Ratio | 0.082 | ▼-0.138 | ▼-0.065 |
| Debt To Capital Ratio | 0.075 | ▼-0.104 | ▼-0.051 |
| Long Term Debt To Capital Ratio | 0.029 | ▼-0.087 | ▲0.000 |
| Financial Leverage Ratio | 1.428 | ▼-0.127 | ▼-0.060 |
| Working Capital Turnover Ratio | 7.902 | ▲1.095 | ▲1.109 |
| Operating Cash Flow Ratio | 0.730 | ▲0.273 | ▲0.332 |
| Operating Cash Flow Sales Ratio | 0.122 | ▲0.039 | ▲0.048 |
| Free Cash Flow Operating Cash Flow Ratio | 0.803 | ▲0.060 | ▲0.761 |
| Debt Service Coverage Ratio | 3.662 | ▼-9.076 | ▼-130.492 |
| Interest Coverage Ratio | 20.146 | ▼-0.594 | ▼-46.683 |
| Short Term Operating Cash Flow Coverage Ratio | 4.502 | ▼-9.805 | ▲0.740 |
| Operating Cash Flow Coverage Ratio | 2.126 | ▲1.626 | ▲1.274 |
| Capital Expenditure Coverage Ratio | 5.078 | ▲1.190 | ▲2.113 |
| Dividend Paid And Capex Coverage Ratio | 2.463 | ▲0.801 | ▲1.086 |
| Dividend Payout Ratio | 0.323 | ▼-0.040 | ▼-0.276 |
| Enterprise Value Multiple | 9.813 | ▼-0.018 | ▼-0.287 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $2.12B | $1.66B | $1.41B | $916.9M | $1.04B | |
| Enterprise value | $2.10B | $1.79B | $1.40B | $984.2M | $1.10B | |
| EV / Sales | 1.38x | 1.38x | 1.23x | 0.92x | 1.09x | |
| EV / Op. cash flow | 11.33x | 16.72x | 12.60x | 112.58x | 17.66x | |
| EV / Free cash flow | 14.11x | 22.51x | 16.82x | -45.87x | 47.91x | |
| EV / EBITDA | 9.81x | 9.83x | 10.69x | 14.41x | 5.75x | |
| Net debt / EBITDA | -0.11x | 0.76x | -0.10x | 0.98x | 0.31x | |
| Current ratio | 1.77x | 1.81x | 1.89x | 1.79x | 1.62x | |
| Income quality | 1.51x | 1.05x | 1.70x | 0.44x | 0.45x | |
| Graham number | $110 | $97 | $76 | $43 | $109 | |
| Graham net-net | -$2 | -$14 | -$6 | -$9 | -$11 | |
| Tax burden | 73.9% | 74.7% | 75.3% | 82.4% | 92.4% | |
| Interest burden | 96.2% | 97.1% | 99.6% | 98.0% | 99.4% | |
| Working capital | $194.5M | $189.6M | $191.8M | $156.0M | $163.4M | |
| Invested capital | $384.9M | $1.14B | $954.6M | $958.4M | $1.02B | |
| Return on assets | 7.9% | 6.7% | 5.1% | 1.8% | 9.9% | |
| Operating ROA | 8.4% | 6.0% | 4.4% | 2.4% | 3.7% | |
| Return on tangible assets | 9.0% | 7.6% | 5.9% | 2.0% | 11.3% | |
| Return on equity | 11.2% | 10.4% | 7.4% | 2.6% | 15.3% | |
| Return on invested capital | 7.4% | 4.8% | 3.7% | 2.1% | 4.0% | |
| Return on capital employed | 10.1% | 6.6% | 5.2% | 3.0% | 4.5% | |
| Earnings yield | 5.7% | 6.2% | 4.7% | 2.4% | 13.3% | |
| Free cash flow yield | 7.0% | 4.8% | 5.9% | -2.3% | 2.2% | |
| Capex / Op. cash flow | 19.7% | 25.7% | 25.1% | 345.5% | 63.1% | |
| Capex / Depreciation | 81.1% | 65.7% | 66.4% | 74.6% | 96.9% | |
| Capex / Sales | 2.4% | 2.1% | 2.4% | 2.8% | 3.9% | |
| SG&A / Sales | 3.0% | 3.3% | 3.6% | 3.8% | 4.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.3% | 0.3% | 0.2% | 0.2% | 0.3% | |
| Intangibles / Total assets | 12.5% | 12.5% | 13.4% | 13.7% | 12.5% | |
| Days sales outstanding | 33d | 38d | 35d | 34d | 35d | |
| Days payables outstanding | 9d | 11d | 10d | 9d | 12d | |
| Operating cycle | 33d | 42d | 39d | 38d | 40d | |
| Cash conversion cycle | 24d | 31d | 29d | 29d | 27d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-30 NHC says 50% chance of cyclone formation in next 48 hours off Louisiana coast An area of low pressure located about 125 miles (200 km) south of the coast of southeastern Louisiana has about a 50% chance of forming into a cyclone in the next 48 hours, the U.S. National Hurricane Center said on Sunday.
- 2026-08-30 Connor Clark & Lunn Investment Management Ltd. Purchases New Position in National HealthCare Corporation $NHC Connor Clark and Lunn Investment Management Ltd. acquired a new stake in National HealthCare Corporation (NYSEAMERICAN:NHC) during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,672 shares of the company''s stock, valued at approximately $1,410,000. Several other institutional investors have also added to or
- 2026-08-30 National HealthCare (NYSEAMERICAN:NHC) Sees Unusually-High Trading Volume – What’s Next? National HealthCare Corporation (NYSEAMERICAN:NHC - Get Free Report) saw strong trading volume on Friday. 91,904 shares were traded during mid-day trading, a decline of 17% from the previous session''s volume of 111,191 shares.The stock last traded at $223.14 and had previously closed at $222.26. Analysts Set New Price Targets Several research firms have recently
- 2026-08-26 BlackRock Inc. Takes $417.60 Million Position in National HealthCare Corporation $NHC BlackRock Inc. acquired a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,975,785 shares of the company''s stock, valued at approximately $417,602,000. BlackRock Inc. owned approximately
- 2026-08-07 NHC Reports Second Quarter 2026 Earnings MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation''s oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended June 30, 2026 totaled $408,025,000 compared to $374,910,000 for the quarter ended June 30, 2025, an increase of 8.8%. The increase in net operating revenues for the second quarter of 2026 was primarily related to the June 1, 2026 acquisition of five skilled nursing facilities. The.
- 2026-08-06 NHC Announces Common Dividend MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation''s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 67 cents per common share to shareholders of record on September 30, 2026 and payable on October 30, 2026. Forward-Looking Statements Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statem.
- 2026-07-01 NHC Completes Acquisition of Thirty-Five NHI Facilities MURFREESBORO, Tenn.--(BUSINESS WIRE)--National Healthcare Corporation (NYSE American: NHC), a national leader in senior care, announced today that it has completed the acquisition of the real estate of thirty-two skilled nursing facilities and three independent living facilities from National Health Investors, Inc. and its affiliates (“NHI”) for a $560 million purchase price. NHC, through affiliates, had been leasing and operating these facilities under a Master Agreement to Lease with NHI orig.
- 2026-06-16 Solace Joins the National Health Council to Advance Patient-Centered Care and Navigation REDWOOD CITY, Calif.--(BUSINESS WIRE)--Solace Health (Solace) today announced its Associate Membership in the National Health Council (NHC), a network of organizations united around patient-centered care and the work of making the healthcare system work better for the patients it was meant to serve. Healthcare advocacy — the work of connecting patients with the expertise and guidance they need to navigate a system not designed with them in mind — sits at the heart of both organizations'' mission.
- 2026-06-04 National HealthCare Corporation Acquires Five Skilled Nursing Facilities in Strategic $50,500,000 Transaction MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), a national leader in senior care, announced today that its affiliates successfully closed the $50,500,000 purchase of five high-performing skilled nursing facilities. The transaction marks a seamless transition for the portfolio, which has been successfully managed by NHC subsidiaries since 1988. The acquisition gives the Murfreesboro, Tennessee-based company full ownership of the operations and real est.